| Issue date | Patent Title | Patent No. | 
| 2022/1/4 | Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine | US11213495 | 
| 2022/1/5 | Opioid receptor modulators and use thereof | MO J/005174 | 
| 2022/1/5 | Heterocyclic compounds and use thereof | MO J/005468 | 
| 2022/1/5 | Heterodimeric Vascular Endothelia Growth Factor and Use Thereof | EP3384029 | 
| 2022/1/7 | Heterocyclic compounds and use thereof | HK1238644 | 
| 2022/1/19 | Thiazolidinone compounds and use thereof | J/005474 | 
| 2022/2/16 | Thiazolidinone compounds and use thereof | KR10-2365673 | 
| 2022/3/1 | Method for calculating activity duration and efficiency | TWI756992 | 
| 2022/3/1 | A vaccine against multiple mosquito-borne flavivirus and methods of preparing and using thereof | TWI756812 | 
| 2022/3/1 | Serum succinate as cancer diagnostic biomarker and anti-succinate monoclonal antibodies for cancer treatment | TWI756870 | 
| 2022/3/2 | Aminothiazole compounds and use thereof | EP3411035 | 
| 2022/3/3 | Aminothiazole compounds as protein kinase inhibitors | KR10-2372288 | 
| 2022/3/4 | Benzimidazole compounds and use thereof for treating alzheimer’s disease or huntington’s disease | JP7035275 | 
| 2022/3/8 | Opioid receptor modulators and use thereof | CA2996281 | 
| 2022/3/8 | Compositions and methods for enhancement of immune responses | US11266728 | 
| 2022/3/11 | Heterocyclic compounds as kinase inhibitors for therapeutic uses | TWI757722 | 
| 2022/3/16 | Cell culture device and electromagnetic stimulation cell culturing system having the same | EP3715447 | 
| 2022/3/29 | CpG-oligodeoxynucleotide, immunogenic composition comprising the same, and methods for preparing the composition and stimulating immune response thereby | CN105530957 | 
| 2022/4/1 | Preparation of antivenom using recombinant toxins thereof | TWI759750 | 
| 2022/4/5 | Primers, SNP markers and method for genotyping Mycobacterium tuberculosis | US11293067 | 
| 2022/4/12 | Thiazole compounds as protein kinase inhibitors | US11299489 | 
| 2022/4/13 | Dipicolylamine derivatives and their pharmaceutical uses | KR102387835 | 
| 2022/4/22 | Heterodimeric vascular endothelial growth factor and use thereof | CN108699562 | 
| 2022/4/26 | A Microfluidic device for loading single cell in large microwells, and the using method threof | CA2995474 | 
| 2022/5/13 | CpG-oligodeoxynucleotide, immunogenic composition, and use thereof | CN109593765 | 
| 2022/5/20 | Thiazolidinone compounds and use thereof | HK1258687 | 
| 2022/5/23 | Aminothiazole compounds as protein kinase inhibitors | RU2772645 | 
| 2022/5/31 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | KR10-2405760 | 
| 2022/6/11 | Cell strain having increased virus production ability and production method thereof | TWI767433 | 
| 2022/6/14 | AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune disease and IL-17A-associated disease | US11360080 | 
| 2022/6/28 | Aminothiazole compounds and use thereof | ZL201780010118.4 | 
| 2022/7/11 | Pyrimidine compounds and their pharmaceutical uses | TWI770858 | 
| 2022/7/12 | Selective particles transfer from one device to another | US11384326 | 
| 2022/7/15 | Aminothiazole compounds as protein kinase inhibitors | MX393992 | 
| 2022/7/20 | Dipicolylamine derivatives and their pharmaceutical uses | EP3145922 | 
| 2022/7/25 | Aminothiazole compounds as protein kinase inhibitors | IN101988 | 
| 2022/7/29 | Nanoemulsion adjuvant for nasal mucosa and preparation method thereof | CN109718372 | 
| 2022/8/10 | Method of Producing Exosomes from Stem Cells and Use Thereof | GB2557696 | 
| 2022/8/23 | Benzimidazole compounds and use thereof for treating alzheimer’s disease or huntington’s disease | CN113613652 | 
| 2022/8/30 | Thiazolidinone compounds and use thereof | JP7132849 | 
| 2022/9/26 | Sub-nanometer gold sticker and methods for protecting against endotoxin-induced sepsis thereof | JP7146937 | 
| 2022/9/27 | Aminothiazole compounds and use thereof | KR10-2449712 | 
| 2022/10/21 | Anti-human neurotensin receptor 1 antibody and use thereof | TWI781647 | 
| 2022/10/21 | Aminothiazole compounds and use thereof | HK1258689 | 
| 2022/11/11 | Methods for prediction, detection and monitoring of substance use disorders and/or an infection | TWI783453 | 
| 2022/11/22 | Opioid receptor modulators and use thereof | JP7181536 | 
 
								